AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33065952 — intervention group
Group type: EXPERIMENTAL
Intervention: 60U daxibotulinumtoxinA
Number of subjects: 191
Study 37863366 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist Depression Service (SDS) offering collaborative treatment with cognitive behavioural therapy (CBT) and pharmacotherapy for 12 months
Number of subjects: 0
Study 37863366 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 37863366 — intervention group
Group type: EXPERIMENTAL
Intervention: SDS
Number of subjects: 0
Study 34274620 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum Neurotoxin (BoNT) treatment
Number of subjects: 14
Study 34274620 — intervention group
Group type: COMPARATOR
Intervention: Baseline ASR response
Number of subjects: 14
Study 34274620 — intervention group
Group type: COMPARATOR
Intervention: Baseline SSR response
Number of subjects: 14
Study 36416367 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical flicker-fusion frequency (CFF) measurement
Number of subjects: 120
Study 36416367 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual fatigue symptom scores
Number of subjects: 120
Study 32996139 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal exercise program including pelvic floor muscle training (12-week standardized program with once weekly group classes and twice weekly home sessions)
Number of subjects: 722
Study 32996139 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care (control group)
Number of subjects: 722
Study 32996139 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal exercise program including pelvic floor muscle training
Number of subjects: 722
Study 32996139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 722
Study 35305593 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus PD-1 blockades
Number of subjects: 84
Study 34608333 — intervention group
Group type: EXPERIMENTAL
Intervention: Talimogene laherparepvec (T-VEC) plus surgery
Number of subjects: 150
Study 34608333 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 150
Study 33313725 — intervention group
Group type: EXPERIMENTAL
Intervention: BCBT‐CP with monthly telehealth booster contacts
Number of subjects: 716
Study 33313725 — intervention group
Group type: COMPARATOR
Intervention: BCBT‐CP without booster contacts
Number of subjects: 716
Study 34774360 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) vaccine
Number of subjects: 160
Study 34774360 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted (AD) vaccine
Number of subjects: 160
Study 34774360 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 160
Study 33000586 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp-acupuncture plus standard care for 14 days (6 days/week)
Number of subjects: 120
Study 33000586 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study 33000586 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp-acupuncture plus standard care
Number of subjects: 120
Study 35130043 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐WRITE
Number of subjects: 497
Study 35130043 — intervention group
Group type: EXPERIMENTAL
Intervention: SD‐WRITE
Number of subjects: 497
Study 35130043 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 497
Study 32950939 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CBT (Daylight™)
Number of subjects: 21
Study 32241795 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA Slim (methotrexate + step-down glucocorticoid)
Number of subjects: 379
Study 32241795 — intervention group
Group type: COMPARATOR
Intervention: COBRA Classic (methotrexate + step-down glucocorticoid + sulphasalazine)
Number of subjects: 379
Study 32241795 — intervention group
Group type: COMPARATOR
Intervention: COBRA Avant-Garde (methotrexate + step-down glucocorticoid + leflunomide)
Number of subjects: 379
Study 32241795 — intervention group
Group type: COMPARATOR
Intervention: Tight-Step-Up (MTX without GCs)
Number of subjects: 379
Study 36159315 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) training (n = 11)
Number of subjects: 20
Study 36159315 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (Control Group, CG) (n = 9)
Number of subjects: 20
Study 33295693 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline nebulization
Number of subjects: 52
Study 33295693 — intervention group
Group type: COMPARATOR
Intervention: Conventional ACT (200 µg of inhaled salbutamol only)
Number of subjects: 52
Study 34748096 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 59
Study 34748096 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 59
Study 34162752 — intervention group
Group type: EXPERIMENTAL
Intervention: Vesatolimod
Number of subjects: 25
Study 34162752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32895247 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + Prone Positioning (PP)
Number of subjects: 24
Study 36050663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 0
Study 36050663 — intervention group
Group type: COMPARATOR
Intervention: Social Skills Training (HOPES/SST)
Number of subjects: 0
Study 33503332 — intervention group
Group type: EXPERIMENTAL
Intervention: Left parietal lobe training (LPL group, n=13)
Number of subjects: 26
Study 33503332 — intervention group
Group type: EXPERIMENTAL
Intervention: Right parietal lobe training (RPL group, n=13)
Number of subjects: 26
Study 33503332 — intervention group
Group type: COMPARATOR
Intervention: Both LPL and RPL groups
Number of subjects: 26
Study 33220323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis 80 mg
Number of subjects: 441
Study 33220323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis 20 mg
Number of subjects: 441
Study 33220323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled Tafamidis (80 mg and 20 mg)
Number of subjects: 441
Study 33220323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study 32616003 — intervention group
Group type: EXPERIMENTAL
Intervention: TightRope® (dynamic device)
Number of subjects: 0
Study 32616003 — intervention group
Group type: COMPARATOR
Intervention: 3.5 mm metallic screw (static implant)
Number of subjects: 0
Study 35612245 — intervention group
Group type: EXPERIMENTAL
Intervention: SP‐ECG
Number of subjects: 33
Study 35612245 — intervention group
Group type: COMPARATOR
Intervention: C‐ECG
Number of subjects: 33
Study 34105767 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg every 8 weeks
Number of subjects: 1829
Study 34105767 — intervention group
Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 1829
Study 36094537 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time prescription benefit recommendations
Number of subjects: 36419
Study 36094537 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RTPB recommendations)
Number of subjects: 36419
Study 35220595 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeland HHRI
Number of subjects: 32
Study 35220595 — intervention group
Group type: EXPERIMENTAL
Intervention: Global C.A.P. HHRI
Number of subjects: 32
Study 35220595 — intervention group
Group type: EXPERIMENTAL
Intervention: HHRIs with early offset-increasing migration pattern
Number of subjects: 32
Study 34147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmyard manure (FYM)
Number of subjects: 3
Study 34147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Slurry
Number of subjects: 3
Study 34147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Methane fermentation digestion liquid (MFDL)
Number of subjects: 3
Study 34147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral fertilizer only (Fert.)
Number of subjects: 3
Study 34147791 — intervention group
Group type: COMPARATOR
Intervention: No-N control (Cont.)
Number of subjects: 3
Study 32794125 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 ppm SeMet
Number of subjects: 3
Study 32794125 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 ppm SeMet
Number of subjects: 3
Study 32794125 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study 35587346 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face CPR training
Number of subjects: 320
Study 35587346 — intervention group
Group type: COMPARATOR
Intervention: Virtual Reality CPR training
Number of subjects: 320
Study 35587346 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study 33640012 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol (4-week course)
Number of subjects: 0
Study 33640012 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 32645234 — intervention group
Group type: EXPERIMENTAL
Intervention: Large volume transfusion (20 mL/kg)
Number of subjects: 39
Study 32645234 — intervention group
Group type: COMPARATOR
Intervention: Standard volume transfusion (15 mL/kg)
Number of subjects: 39
Study 36010894 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid mesh sheet (Neoveil™) applied after fibrin glue
Number of subjects: 330
Study 36010894 — intervention group
Group type: COMPARATOR
Intervention: Control group with only fibrin glue
Number of subjects: 330
Study 33402707 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (hypothermia arm from three RCTs)
Number of subjects: 280
Study 35815754 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion by straight men
Number of subjects: 194
Study 35815754 — intervention group
Group type: COMPARATOR
Intervention: Inclusion by straight men
Number of subjects: 194
Study 35815754 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion by gay men
Number of subjects: 194
Study 35815754 — intervention group
Group type: COMPARATOR
Intervention: Inclusion by gay men
Number of subjects: 194
Study 33606902 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide
Number of subjects: 6480
Study 33606902 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6480
Study 32291291 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention (PSI)
Number of subjects: 100
Study 32291291 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 100
Study 35838488 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0
Study 35838488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35838488 — intervention group
Group type: COMPARATOR
Intervention: Other vasoconstrictors
Number of subjects: 0
Study 32789503 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-WBRT
Number of subjects: 65
Study 32789503 — intervention group
Group type: COMPARATOR
Intervention: C-WBRT
Number of subjects: 65
Study 35338577 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy intervention for renal fatigue
Number of subjects: 24
Study 35338577 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 34413064 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate endovascular treatment
Number of subjects: 366
Study 34413064 — intervention group
Group type: COMPARATOR
Intervention: No information regarding the patient's profession
Number of subjects: 366
Study 34413064 — intervention group
Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 366
Study 34413064 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants older than 60 years
Number of subjects: 366
Study 34413064 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with more experience in neurointervention
Number of subjects: 366
Study 34413064 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who personally performed >100 endovascular treatments per year
Number of subjects: 366
Study 32557302 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralized Clinical Trials (DCTs) recommendations
Number of subjects: 0
Study 35795564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 250 mg
Number of subjects: 100
Study 35795564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 1000 mg
Number of subjects: 100
Study 35795564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 1500 mg
Number of subjects: 100
Study 35795564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33917916 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 week low-dose combined resistance and endurance training program (TG)
Number of subjects: 40
Study 33917916 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study 33053048 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming (FAW) with pre-warmed Ringer's solution
Number of subjects: 62
Study 33053048 — intervention group
Group type: COMPARATOR
Intervention: Control group with Ringer's solution without FAW
Number of subjects: 62
Study 33053048 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming (FAW)
Number of subjects: 62
Study 36423442 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus up to 26 sessions of TwV therapy
Number of subjects: 50
Study 36423442 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 50
Study 34543267 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered integrated chronic care model including treatment for hypertension, diabetes, and HIV.
Number of subjects: 10928
Study 34543267 — intervention group
Group type: COMPARATOR
Intervention: Standard country-guided treatment (control group).
Number of subjects: 10928
Study 36322925 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling during bottle feeding
Number of subjects: 30
Study 36322925 — intervention group
Group type: COMPARATOR
Intervention: Unswaaddled during bottle feeding
Number of subjects: 30
Study 35035312 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinkuei Shin Chewan Decoction
Number of subjects: 110
Study 35035312 — intervention group
Group type: COMPARATOR
Intervention: Traditional medicine
Number of subjects: 110
Study 35035312 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence-based U-net registration algorithm
Number of subjects: 110
Study 32652527 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36619724 — intervention group
Group type: EXPERIMENTAL
Intervention: HP eradication treatment
Number of subjects: 40
Study 36619724 — intervention group
Group type: COMPARATOR
Intervention: Standard NASH treatment
Number of subjects: 40
Study 34728848 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mm Endo GIA stapler
Number of subjects: 16
Study 34728848 — intervention group
Group type: COMPARATOR
Intervention: Suture ligation
Number of subjects: 16
Study 32567544 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 60
Study 32567544 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination sitagliptin and metformin
Number of subjects: 60
Study 32567544 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 60
Study 35468325 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg and 15 mg
Number of subjects: 296
Study 35468325 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec
Number of subjects: 296
Study 35468325 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide groups
Number of subjects: 296
Study 33481032 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-trained model applied to EHR data
Number of subjects: 2113
Study 33481032 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-trained model
Number of subjects: 2113
Study 32563025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) from a single donor, administered three times with an interval of 2-3 months.
Number of subjects: 16
Study 32563025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 16
Study 36153518 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and Vegetable Intervention Arm (weekly counseling and supplemental fruit and vegetable box delivery for 20 weeks)
Number of subjects: 400
Study 36153518 — intervention group
Group type: COMPARATOR
Intervention: USDA MyPlate Control Arm (standard dietary guidance)
Number of subjects: 400
Study 32376732 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ) (12.9 mmol nitrate), consumed 3 hours prior to each PR session.
Number of subjects: 165
Study 32376732 — intervention group
Group type: COMPARATOR
Intervention: Placebo nitrate-deplete BRJ, consumed 3 hours prior to each PR session.
Number of subjects: 165
Study 35581902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose lobeglitazone (0.25 mg/day)
Number of subjects: 0
Study 35581902 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose lobeglitazone (0.5 mg/day)
Number of subjects: 0
Study 34044810 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with sintilimab
Number of subjects: 163
Study 34044810 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy only
Number of subjects: 163
Study 32310197 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented circuit training (TOCT)
Number of subjects: 20
Study 32310197 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - relaxation exercises
Number of subjects: 20
Study 34847841 — intervention group
Group type: EXPERIMENTAL
Intervention: FilmArray® Pneumonia Panel plus (FAP plus)
Number of subjects: 0
Study 34847841 — intervention group
Group type: COMPARATOR
Intervention: Routine diagnostics (RT‐PCR and ID NOW™ Influenza A and B 2)
Number of subjects: 0
Study 34847841 — intervention group
Group type: EXPERIMENTAL
Intervention: ID NOW™ Influenza A and B 2
Number of subjects: 0
Study 33179399 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive focal site ablation
Number of subjects: 80
Study 33179399 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary vein isolation
Number of subjects: 80
Study 35431027 — intervention group
Group type: EXPERIMENTAL
Intervention: U‐shaped tube embedded with radiopaque markers
Number of subjects: 11
Study 35431027 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic tooth cusps
Number of subjects: 11
Study 35431027 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone markers with random number table method
Number of subjects: 11
Study 34682394 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-tailored report back process
Number of subjects: 87
Study 32885263 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard withdrawal (≥6 or 8 minutes)
Number of subjects: 311
Study 32885263 — intervention group
Group type: COMPARATOR
Intervention: Segmental withdrawal (≥3 or ≥4 minutes dedicated to the right side, minimum withdrawal time of ≥6 or 8 minutes)
Number of subjects: 311
Study 34231546 — intervention group
Group type: EXPERIMENTAL
Intervention: Home- or community-based exercise program with formal instruction and health care provider involvement
Number of subjects: 15
Study 34231546 — intervention group
Group type: EXPERIMENTAL
Intervention: Home- or community-based exercise program
Number of subjects: 15
Study 32445718 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 963829
Study 32445718 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 963829
Study 35089153 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy (iCBT) for 5 weeks
Number of subjects: 109
Study 35089153 — intervention group
Group type: COMPARATOR
Intervention: psychoeducation for 5 weeks
Number of subjects: 109
Study 35089153 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy (iCBT)
Number of subjects: 109
Study 35089153 — intervention group
Group type: COMPARATOR
Intervention: psychoeducation
Number of subjects: 109
Study 33723721 — intervention group
Group type: EXPERIMENTAL
Intervention: TensioBot (chatbot assistant)
Number of subjects: 112
Study 33723721 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chatbot)
Number of subjects: 112
Study 33142448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bisulfate (SB)
Number of subjects: 1200
Study 33142448 — intervention group
Group type: COMPARATOR
Intervention: Challenged control
Number of subjects: 1200
Study 36028376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual plating (Group 1 and Group 3)
Number of subjects: 20
Study 36028376 — intervention group
Group type: COMPARATOR
Intervention: Lateral plating (Group 2 and Group 4)
Number of subjects: 20
Study 36028376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual plating (Group 3)
Number of subjects: 20
Study 36028376 — intervention group
Group type: COMPARATOR
Intervention: Lateral plating (Group 4)
Number of subjects: 20
Study 33670474 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time visual feedback training (VFT)
Number of subjects: 26
Study 33670474 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 26
Study 35532064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light (10,000 lux) applied for 30 minutes every morning for 14 days
Number of subjects: 52
Study 35532064 — intervention group
Group type: COMPARATOR
Intervention: Dim red light (<50 lux) applied for 30 minutes every morning for 14 days
Number of subjects: 52
Study 34237697 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced nutritional supplement
Number of subjects: 27
Study 34237697 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional supplement
Number of subjects: 27
Study 34237697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both supplements
Number of subjects: 27
Study 36118671 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT continuous care
Number of subjects: 90
Study 36118671 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 90
Study 33813906 — intervention group
Group type: EXPERIMENTAL
Intervention: New intervention
Number of subjects: 0
Study 32120787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of water-soluble coenzyme Q10 (Q10Vital®) and collagen
Number of subjects: 34
Study 32120787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34